# Chemed Corp: Form 10-K for the period ended Dec 31, 2014

- Company: [Chemed Corp](/companies/che.md) (CIK 19584)
- Form: 10-K
- Filed: 2015-02-27
- Accepted by EDGAR: Feb 27, 2015, 08:14 ET
- Period: 2014-12-31
- Accession: 0001157523-15-000756
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/19584/000115752315000756/a51044635.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/19584/000115752315000756/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2014-01-01 to 2014-12-31 | $1.46bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months, 2014-01-01 to 2014-12-31 | $1.03bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 12 months, 2014-01-01 to 2014-12-31 | $220.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2014-01-01 to 2014-12-31 | $168.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2014-01-01 to 2014-12-31 | $8.2m | us-gaap:InterestExpense |
| Income tax | 12 months, 2014-01-01 to 2014-12-31 | $63.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2014-01-01 to 2014-12-31 | $99.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2014-01-01 to 2014-12-31 | $5.57 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2014-01-01 to 2014-12-31 | $5.79 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2014-01-01 to 2014-12-31 | 17,840,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2014-01-01 to 2014-12-31 | $110.3m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months, 2014-01-01 to 2014-12-31 | $43.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2014-01-01 to 2014-12-31 | $14.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months, 2014-01-01 to 2014-12-31 | $110.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2014-12-31 | $14.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-12-31 | $174.6m | us-gaap:AssetsCurrent |
| Total assets | at 2014-12-31 | $859.9m | us-gaap:Assets |
| Current liabilities | at 2014-12-31 | $175.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-12-31 | $408.6m | us-gaap:Liabilities |
| Long-term debt | at 2014-12-31 | $141.3m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2014-12-31 | $6.3m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2014-12-31 | $451.4m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/19584/000115752315000756/a51044635.htm

Filed Feb 27, 2015.
Source: SEC EDGAR, the filing index for accession 0001157523-15-000756. Last ingested by Listed: Nov 14, 2026, 12:29 ET. No prices; not investment advice.
